Answered step by step
Verified Expert Solution
Link Copied!

Question

1 Approved Answer

You are valuing BioNTech SE, a very young biotechnology firm, with no revenues. Thecompany has a blockbuster drug working its way through the pipeline and

You are valuing BioNTech SE, a very young biotechnology firm, with no revenues. Thecompany has a blockbuster drug working its way through the pipeline and if it is approved (approximately 2years from now), it expects to generate $1 billion in after-tax cash flows from the drug every year for the following 15 years. The cost of capital of small pharmaceutical companies is 10% and there is only a 40% chance that the drug will be approved. BioNTech has very little cash, no debt and 125million shares outstanding. Estimate the value per share today, assuming that the blockbuster drug is itsonly potential product.

Step by Step Solution

There are 3 Steps involved in it

Step: 1

blur-text-image

Get Instant Access to Expert-Tailored Solutions

See step-by-step solutions with expert insights and AI powered tools for academic success

Step: 2

blur-text-image

Step: 3

blur-text-image

Ace Your Homework with AI

Get the answers you need in no time with our AI-driven, step-by-step assistance

Get Started

Recommended Textbook for

Analysis for Financial Management

Authors: Robert C. Higgins

10th edition

007803468X, 978-0078034688

More Books

Students also viewed these Finance questions

Question

Focus on the interview.

Answered: 1 week ago